Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
08 Jul 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]US Exclusivities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Indigo Carmine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indigo Carmine, including repackagers and relabelers. The FDA regulates Indigo Carmine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indigo Carmine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Indigo Carmine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Indigo Carmine supplier is an individual or a company that provides Indigo Carmine active pharmaceutical ingredient (API) or Indigo Carmine finished formulations upon request. The Indigo Carmine suppliers may include Indigo Carmine API manufacturers, exporters, distributors and traders.
click here to find a list of Indigo Carmine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Indigo Carmine DMF (Drug Master File) is a document detailing the whole manufacturing process of Indigo Carmine active pharmaceutical ingredient (API) in detail. Different forms of Indigo Carmine DMFs exist exist since differing nations have different regulations, such as Indigo Carmine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Indigo Carmine DMF submitted to regulatory agencies in the US is known as a USDMF. Indigo Carmine USDMF includes data on Indigo Carmine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Indigo Carmine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Indigo Carmine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Indigo Carmine Drug Master File in Japan (Indigo Carmine JDMF) empowers Indigo Carmine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Indigo Carmine JDMF during the approval evaluation for pharmaceutical products. At the time of Indigo Carmine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Indigo Carmine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Indigo Carmine Drug Master File in Korea (Indigo Carmine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Indigo Carmine. The MFDS reviews the Indigo Carmine KDMF as part of the drug registration process and uses the information provided in the Indigo Carmine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Indigo Carmine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Indigo Carmine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Indigo Carmine suppliers with KDMF on PharmaCompass.
A Indigo Carmine written confirmation (Indigo Carmine WC) is an official document issued by a regulatory agency to a Indigo Carmine manufacturer, verifying that the manufacturing facility of a Indigo Carmine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Indigo Carmine APIs or Indigo Carmine finished pharmaceutical products to another nation, regulatory agencies frequently require a Indigo Carmine WC (written confirmation) as part of the regulatory process.
click here to find a list of Indigo Carmine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Indigo Carmine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Indigo Carmine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Indigo Carmine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Indigo Carmine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Indigo Carmine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Indigo Carmine suppliers with NDC on PharmaCompass.
Indigo Carmine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indigo Carmine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indigo Carmine GMP manufacturer or Indigo Carmine GMP API supplier for your needs.
A Indigo Carmine CoA (Certificate of Analysis) is a formal document that attests to Indigo Carmine's compliance with Indigo Carmine specifications and serves as a tool for batch-level quality control.
Indigo Carmine CoA mostly includes findings from lab analyses of a specific batch. For each Indigo Carmine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indigo Carmine may be tested according to a variety of international standards, such as European Pharmacopoeia (Indigo Carmine EP), Indigo Carmine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indigo Carmine USP).
LOOKING FOR A SUPPLIER?
Comment (3)
